OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.820
+0.050 (1.33%)
May 8, 2025, 3:30 PM HKT

OrbusNeich Medical Group Holdings Company Description

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacturing, trading, sales, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States.

The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expandable stent system.

Its product portfolio covers various treatment processes in percutaneous coronary intervention and percutaneous transluminal angioplasty procedures.

The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.

OrbusNeich Medical Group Holdings Limited
Country Cayman Islands
Founded 2001
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 1,331
CEO David Chien

Contact Details

Address:
Building 20E
Sha Tin
Hong Kong
Phone 852 2802 2288
Website orbusneich.com

Stock Details

Ticker Symbol 6929
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency USD
ISIN Number KYG6773B1005
SIC Code 3842

Key Executives

Name Position
David Chien Chairman of the Board and Chief Executive Officer
Wing Shing Chen Chief Financial Officer, Company Secretary and Executive Director
Kwai Ching Lau Chief Operating Officer and Executive Director
Alain Djamel Khair Chief Commercial Officer